11-66704803-T-C
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_006946.4(SPTBN2):āc.2473A>Gā(p.Ser825Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.998 in 1,605,840 control chromosomes in the GnomAD database, including 799,413 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_006946.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTBN2 | NM_006946.4 | c.2473A>G | p.Ser825Gly | missense_variant | 15/38 | ENST00000533211.6 | NP_008877.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTBN2 | ENST00000533211.6 | c.2473A>G | p.Ser825Gly | missense_variant | 15/38 | 5 | NM_006946.4 | ENSP00000432568.1 |
Frequencies
GnomAD3 genomes AF: 0.988 AC: 150483AN: 152240Hom.: 74398 Cov.: 36
GnomAD3 exomes AF: 0.997 AC: 235946AN: 236580Hom.: 117660 AF XY: 0.998 AC XY: 129949AN XY: 130206
GnomAD4 exome AF: 0.999 AC: 1451667AN: 1453482Hom.: 724957 Cov.: 106 AF XY: 0.999 AC XY: 722556AN XY: 723376
GnomAD4 genome AF: 0.988 AC: 150600AN: 152358Hom.: 74456 Cov.: 36 AF XY: 0.989 AC XY: 73724AN XY: 74510
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 08, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Autosomal recessive spinocerebellar ataxia 14 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Spinocerebellar ataxia type 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at